STOCK TITAN

Guardant Health to Report First Quarter 2025 Financial Results on April 30, 2025

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

Guardant Health (Nasdaq: GH) has scheduled its first quarter 2025 financial results announcement for April 30, 2025, after market close. The precision oncology company will host a conference call and webcast at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on the same day. Investors can access the live audio webcast through the company's website investor section, and a replay will be available after the event.

Guardant Health (Nasdaq: GH) ha programmato l'annuncio dei risultati finanziari del primo trimestre 2025 per il 30 aprile 2025, dopo la chiusura del mercato. L'azienda di oncologia di precisione ospiterà una conference call e un webcast alle 13:30 ora del Pacifico / 16:30 ora dell'Est dello stesso giorno. Gli investitori possono accedere al webcast audio dal vivo attraverso la sezione investitori del sito web dell'azienda, e una registrazione sarà disponibile dopo l'evento.

Guardant Health (Nasdaq: GH) ha programado el anuncio de sus resultados financieros del primer trimestre de 2025 para el 30 de abril de 2025, después del cierre del mercado. La compañía de oncología de precisión llevará a cabo una conferencia telefónica y un webcast a la 1:30 p.m. hora del Pacífico / 4:30 p.m. hora del Este el mismo día. Los inversores pueden acceder al webcast de audio en vivo a través de la sección de inversores del sitio web de la compañía, y una repetición estará disponible después del evento.

Guardant Health (Nasdaq: GH)는 2025년 1분기 재무 결과 발표를 2025년 4월 30일, 시장 마감 후로 예정하고 있습니다. 정밀 종양학 회사는 같은 날 태평양 표준시 오후 1시 30분 / 동부 표준시 오후 4시 30분에 컨퍼런스 콜과 웹캐스트를 개최할 예정입니다. 투자자들은 회사 웹사이트의 투자자 섹션을 통해 실시간 오디오 웹캐스트에 접근할 수 있으며, 이벤트 후에는 다시보기도 제공될 것입니다.

Guardant Health (Nasdaq: GH) a programmé l'annonce de ses résultats financiers pour le premier trimestre 2025 pour le 30 avril 2025, après la fermeture du marché. L'entreprise de cancérologie de précision organisera une conférence téléphonique et un webcast le même jour à 13h30, heure du Pacifique / 16h30, heure de l'Est. Les investisseurs peuvent accéder au webcast audio en direct via la section investisseurs du site web de l'entreprise, et un enregistrement sera disponible après l'événement.

Guardant Health (Nasdaq: GH) hat die Bekanntgabe seiner finanziellen Ergebnisse für das erste Quartal 2025 auf den 30. April 2025, nach Börsenschluss, terminiert. Das Unternehmen für präzise Onkologie wird am selben Tag um 13:30 Uhr pazifischer Zeit / 16:30 Uhr östlicher Zeit eine Telefonkonferenz und einen Webcast veranstalten. Investoren können über den Investorenbereich der Unternehmenswebsite auf den Live-Audio-Webcast zugreifen, und eine Wiederholung wird nach der Veranstaltung verfügbar sein.

Positive
  • None.
Negative
  • None.

PALO ALTO, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the first quarter 2025 after market close on Wednesday, April 30, 2025. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Live audio of the webcast will be available on the “Investors” section of the company website at: www.guardanthealth.com. The webcast will be archived and available for replay after the event.

About Guardant Health

Guardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care and accelerating new cancer therapies by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and treatment selection for patients with advanced cancer. For more information, visit guardanthealth.com and follow the company on LinkedIn, X (Twitter) and Facebook.

Source: Guardant Health, Inc.

Investor Contact:

Zarak Khurshid

investors@guardanthealth.com

Media Contact:

Melissa Marasco

press@guardanthealth.com

+1 650-647-3711

Source: Guardant Health, Inc.

FAQ

When will Guardant Health (GH) release Q1 2025 earnings?

Guardant Health will release Q1 2025 earnings on April 30, 2025, after market close.

What time is Guardant Health's (GH) Q1 2025 earnings call?

The earnings call is scheduled for 1:30 PM PT / 4:30 PM ET on April 30, 2025.

How can investors access Guardant Health's (GH) Q1 2025 earnings call?

Investors can access the live webcast through the 'Investors' section at www.guardanthealth.com.

Will Guardant Health's (GH) Q1 2025 earnings call be available for replay?

Yes, the webcast will be archived and available for replay after the event.
Guardant Health

NASDAQ:GH

GH Rankings

GH Latest News

GH Stock Data

5.57B
117.48M
4.71%
98.48%
6.4%
Diagnostics & Research
Services-medical Laboratories
Link
United States
PALO ALTO